rnai is well known for its ability to regulate gene expression in the cytoplasm of mammalian cells. In mammalian cell nuclei, however, the impact of rnai has remained more controversial. a key technical hurdle has been a lack of optimized protocols for the isolation and analysis of cell nuclei. Here we describe a simplified protocol for nuclei isolation from cultured cells that incorporates a method for obtaining nucleoplasmic and chromatin fractions and removing cytoplasmic contamination. cell fractions can then be used to detect the presence and activity of rnai factors in the nucleus. We include a method for investigating an early step in rnai, argonaute protein loading with small rnas, which is enabled by our improved extract preparations. this protocol facilitates the characterization of nuclear rnai, and it can be applied to the analysis of other nuclear proteins and pathways. From cellular fractionation to analysis of argonaute loading results, this protocol takes 4-6 d to complete.
IntroDuctIon
RNAi is a regulatory mechanism in which cellular proteins associate with small RNAs. The resultant ribonucleoprotein complexes recognize complementary sequences within cellular RNA targets to control gene expression 1 . Although it was first recognized in Caenorhabditis elegans 2 , Elbashir et al. 3 demonstrated that RNAi could also be programmed with small RNAs to function in mammalian cells. Since that discovery, RNAi in the mammalian cytoplasm has become a ubiquitous research tool and has been widely recognized as an important mechanism for controlling the expression of endogenous proteins.
Transcription and splicing are crucial processes that involve RNA and occur in cell nuclei. If the cellular RNAi machinery that drives recognition in the cytoplasm also operates in the nucleus, transcription or splicing might also be affected by RNAi. For example, recognition of a sequence near a splice site might alter splicing. Recognition of a nascent transcript near a gene promoter or enhancer region might affect transcription. Such events would represent a previously unappreciated layer of biological control and imply that microRNAs (miRNAs) have a much wider range of cellular roles.
Several groups have made experimental observations suggesting that RNAi factors might be involved in regulating gene expression in the nucleus of mammalian cells. These include observations of RNA-mediated inhibition of transcription [4] [5] [6] [7] [8] [9] , activation of transcription [10] [11] [12] [13] and control of alternative splicing 14, 15 . Transcriptional activation and silencing has been reported to be dependent on RNAi factors such as Argonaute 9, 12, 16, 17 and GW182 (ref. 12) . Surprisingly, given the broad potential of nuclear RNAi to affect gene expression in mammalian cells, relatively little research on the topic has been published, and few researchers have entered the field. Our impression from informal discussions at meetings and from anonymous peer review led us to conclude that a significant number of RNA biologists believed that RNAi factors are either not present or not active in mammalian cell nuclei. This belief has helped discourage research on nuclear RNAi in mammalian cells and dampened the chances for significant progress.
Motivated by this unofficial consensus among many RNA biologists that nuclear RNAi was, at best, an uncertain phenomenon, we re-examined published evidence. Some studies had concluded that RNAi factors are inactive in mammalian cell nuclei 18, 19 . Localization studies had shown the presence of RNAi factors in cytoplasmic p-bodies or associated with the endoplasmic reticulum (ER) 20, 21 . In contrast, other data suggested the presence or activity of RNAi factors in cell nuclei 17, [22] [23] [24] [25] [26] [27] . As noted above, RNAi factors appeared to be involved in RNA-mediated control of transcription and splicing. These conflicting data were insufficient to conclusively determine whether the necessary RNAi factors were also nuclear and, if so, whether they were active.
Here we describe an improved protocol for obtaining nuclear fractions from cultured human cells and an in vitro assay for investigating Argonaute loading activity using these nuclear fractions. By combining these methods with complementary approaches, we have shown that RNAi factors are present and active in the human cell nucleus, but that loading of Argonaute-2 (Ago2) occurs in the cytoplasm 28 . This protocol will be useful for investigating RNAi activity in human cell nuclei. Our approach to obtaining cleaner nuclei and subnuclear fractions will also facilitate biochemical investigation of other nuclear processes where rigorous exclusion of organelle contamination, such as the ER, is necessary.
Protocol development
We concluded that it was necessary to re-examine the techniques used to evaluate nuclear localization and activity of RNAi factors. We immediately identified a key technical challenge. Any experiment designed to clarify whether or not a cellular activity exists in cell nuclei must build a strong case that nuclear extracts are free of cytosolic or cytoplasmic organelle contamination 29 . This is especially true for RNAi studies, as Ago proteins are known to be associated with the ER 21 . The ER is attached to the outer nuclear membrane and it can be difficult to dissociate 30 . The implications of ER contamination for interpreting Ago localization have been previously noted 29 .
We found that standard methods often do not adequately or reliably remove ER proteins from purified nuclei 28 . These include protocols where complicated sucrose cushions are used to separate nuclei from other cellular organelles or large cell debris 31, 32 . To optimize nuclei isolation, we took advantage of the ability of nonionic detergents to strip membrane proteins from the ER while keeping the nuclear membrane intact 28, 31 . Differential centrifugation speeds were also explored for the separation of nuclei from contaminating organelles and cell debris without resorting to sucrose cushions. We developed the protocol by systematically varying the identity and concentration of the detergent, nuclei washing conditions and centrifugation speeds used to separate and wash nuclei. To evaluate purifications, we examined nuclei purity using fluorescence microscopy to detect ER integral membrane protein and western blot analysis to detect ER components and other cytoplasmic contaminants such as mitochondria. The resulting protocol removes ER proteins and other cytoplasmic contaminants while keeping nuclei intact.
The presence of RNAi factors in cell nuclei does not address whether they will be active. To answer this question, we used our nuclei purification protocol to obtain extracts suitable for biochemical studies. These studies include sequencing of small RNAs bound to Ago2 and assays to monitor Ago2-mediated cleavage, Dicer cleavage and small RNA loading of Ago2 (ref. 28) . As no published protocols were found for directly evaluating in vitro loading of Ago proteins in cell extracts, a key early step in RNAi, we developed our own. It is important to directly assess Argonaute loading of small RNAs, as this step in RNAi is distinct from target RNA engagement and cleavage, and the activities of these steps may not directly correlate. By using our loading assay, we demonstrated that RNAi programming via Ago2 loading was deficient in nuclear extracts owing to the absence of the known loading factors C3PO and Hsp90 and its co-chaperones. Ago2 loading only occurred in the cytoplasm, suggesting a novel layer of RNAi regulation in the nucleus 28 .
Applications of the method
The need for nuclear preparations free of ER protein contamination and other cytoplasmic contaminants is shared by many experimental approaches. In addition, there is often a need to simultaneously assay RNA, protein and enzyme activities from these fractions and to physically separate soluble nuclear and insoluble chromatin-associated nuclear fractions. Our subcellular fractionation approach is flexible and we have demonstrated its Step 7A(ii) and 7A(viii)
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Biochemistry/ protein analysis RNA analysis application for checking RNA levels by quantitative PCR (qPCR), RNA cleavage products by 5′-rapid amplification of cloned ends (RACE), RNA-protein interactions by sequencing, protein levels by western blotting and enzyme activities by in vitro biochemical assays 28 .
In this protocol, we present fractionation techniques for multiple end-point assays and demonstrate their use in a direct biochemical assay, Ago2 small RNA loading. Although we focus on RNAi factors, this approach is readily adapted for RNA and general protein isolation, and we describe protocols to obtain fractions for these purposes. These protocols should find wide application for a variety of experimental investigations of function within the nuclear compartment of mammalian cells.
Overview of the procedure A schematic of the major end points in the cell fractionation and extract preparation is provided in Figure 1 . Briefly, cells are collected and weighed or counted, and they are then lysed to generate cytoplasmic extract and nuclei. Nuclei are washed and directly lysed by sonication or incubation with TRIzol reagent, or are further fractionated to collect soluble nuclear (nucleoplasmic) or insoluble nuclear (chromatin-associated) fractions. From each fraction, protein or RNA can be isolated, or fractions can be used for biochemical assays. A schematic of the Ago2 loading assay is shown in Figure 2 . The accessibility of Ago2 for binding small RNA is evaluated by incubation of radiolabeled siRNA with isolated Ago2. Ago2 duplex RNA loading activity is assessed by incubation of duplex small RNA with extract, followed by immunoprecipitation of Ago2. Radiolabeled RNA that co-purifies with Ago2 represents Ago2-bound and Ago2-loaded siRNA, which is then extracted and resolved by gel electrophoresis for visualization.
Collection of tissue culture cells (Steps 1-6).
We have successfully used adherent HeLa, T47D, A549 and untransformed fibroblast cells for the protocols described here 28 . On the basis of our experience, we expect that these protocols will be applicable to a wide variety of mammalian tissue culture cells. It is expected that the user will have some experience with tissue culture and existing protocols for how to grow and maintain healthy cell cultures. For the protocol described here, we recommend HeLa cells as they are straightforward to culture. HeLa cells are cultured in DMEM supplemented with 5% (vol/vol) FBS and 0.5% (vol/vol) nonessential amino acids (NEAA). Cells are grown in sterile incubators at 37 °C in 5% CO 2 .
The time required to grow a sufficient number of cells varies from 3 to 7 d, depending on the number of cells initially seeded. For the production of sufficient quantities of cell extract, seeding and growth of cells in multiple large flasks, such as ten or more 15-cm dishes, is recommended. To maximize cell numbers, cells are collected when they are close to 90% confluency. However, some tissue culture cell types are more sensitive to crowding and may need to be collected sooner, depending on future applications of the extract. For experiments such as in vitro Ago2 loading and RNAi factor localization, cell confluency did not appear to markedly affect our results.
Subcellular fractionation (Step 7 and Box 1).
Gentle pipetting is key to successful fractionation, so as not to lyse nuclei during the initial cell lysis; this should be followed by low-speed centrifugation during wash steps to separate cytoplasmic debris and organelles from the isolated nuclei. The varying properties of different cell types mean that some protocol optimization may be required. For example, fibroblasts are larger cells, and therefore they have larger nuclei and a stronger cell membrane compared with HeLa cells. Accordingly, we have found that efficient fibroblast lysis required more pipetting and an additional 5 min of incubation on ice. However, during nuclei washing, lower speeds of 100g were sufficient to pellet and wash nuclei. We also observed that T47D cell nuclei usually need to be spun at higher speeds, up to 300g, for efficient washing.
Nuclei purity can be directly visualized by fluorescence microscopy using a DAPI stain (nuclear chromatin) and ER Tracker dye (ER integral membrane protein) 28 . Visualization of nuclei integrity and efficient ER protein removal is an important quality control checkpoint when beginning these experiments for the first time (Box 1). After washing, nuclei are incubated with ER Tracker dye, and then they are diluted and spotted to glass coverslips and set with mounting medium containing DAPI. For imaging, a confocal or wide-field microscope with blue and red fluorescence capability is sufficient. Once nuclei have been thoroughly washed, they are disrupted to make nuclear extract. Extracts should be kept on ice and flash-frozen in liquid nitrogen for storage at −80 °C. Extract quality is typically assessed by western blot analysis of subcellular marker proteins.
The subcellular fractionation protocol described here is quite flexible and can be adapted for various downstream assays. Here we detail how to obtain cytoplasmic, nuclear, nucleoplasmic and chromatin fractions and to either isolate RNA or protein Ago2 small RNA accessibility
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Step 10A(i-iii) or 10B(i-iii) for analysis, or to make extracts suitable for biochemical study. Analysis of RNA levels or identity often needs to be performed in replicate. Therefore, it is important to count cells and to make aliquots with equivalent numbers for each sample or treatment. During the isolation of RNA, both nuclei and chromatin can be directly dissolved in TRIzol reagent. However, cytoplasmic and nucleoplasmic fractions are in liquid phase. To efficiently extract RNA, both RNA and protein are first precipitated, and then the pellet is dissolved in TRIzol and heated. As an alternative to precipitation, TRIzol designed for liquid samples or phenol may be used to directly extract RNA. However, the efficiency of these alternatives has not been tested. A heating step is necessary, especially for the chromatin sample, to completely dissolve the precipitate or chromatin. Base-pairing of genomic DNA is not effectively denatured in TRIzol, so heating releases bound histones, denatures the hybridized strands and efficiently releases associated RNA. Sonication of the chromatin pellet is not recommended, as it will substantially increase levels of DNA contamination in downstream assays. Subsequent analysis of RNA must include a DNA removal step, such as DNase treatment, to ensure analysis of RNA only.
Preparation of subnuclear extracts for biochemical assays may require further processing for subsequent use. Nucleoplasmic fractions contain 1 M urea. Many enzyme assays will be sensitive to chaotropic agents such as urea, and the extract may need to be dialyzed or diluted beforehand. Chromatin fractions will contain fragmented genomic DNA from sonication, which may inhibit some activity assays. This DNA can be removed by treatment with DNase. If chromatin fractions are being prepared for western blot analysis, they can be directly boiled in SDS loading buffer rather than sonicated. After cooling, genomic DNA will reanneal but extracted protein can be recovered, largely free of any genomic DNA, by filtering through spin-filtration columns, as the genomic DNA will stick to the spin filter and will not flow through. If DNA is not removed, bands on the gel will tend to smear. The filtering step helps remove DNA and results in sharper gel images.
Radiolabeling RNA (Box 2). Although 5′-end radiolabeling of RNA is a standard procedure, we described our method here because it requires special considerations, including the differential labeling of the siRNA guide strand, annealing to the passenger strand and purification on a native gel, high specific activity labeling, and precipitation with an uncommon reagent.
Differential labeling of the guide strand is achieved by labeling it before mixing it with the passenger strand. The success of the subsequent Ago2 loading assay in cell extracts requires purified siRNA of very high specific radioactivity, on the order of 0.5-2 × 10 6 c.p.m. per loading reaction. Key aspects of this method are the use of [γ]-32 P ATP with high specific activity, gel purification on a native gel to preserve native duplex siRNA structure, and a highly efficient precipitation method after gel purification using lithium perchlorate (LiClO 4 ) in acetone. Gel purification of radiolabeled RNA of low quantity requires visualization and orientation of the RNA bands, as they cannot be stained. To do this, we describe the simple use of radioactive dye spotted asymmetrically at the corners of a gel, followed by exposure to a film, which can then be slid underneath the gel to identify bands and extract them.
The siRNA used in this protocol targets a sequence of the luciferase mRNA 3, 28 . There are no special considerations when choosing an siRNA or duplex RNA for this method. However, standard siRNA designs should be used initially or as controls, such as a duplex RNA of 21 nt that contains 3′ dTdT overhangs 3 . This method can serve as a tool to evaluate the structural and sequence requirements of various RNAs for loading into Argonaute proteins.
Ago2 loading assay (Steps 8-10).
For in vitro Ago2 loading assays, loading needs to be performed in the extract before Ago2 is subsequently captured with immunoaffinity resin. If Ago2 is bound to the resin first, duplex siRNA loading is inefficient. Thus, resin and antibody should not be mixed with the siRNA and extract together, but should only be added after an initial time of Ago2 loading in solution. It is important to centrifuge samples before the addition of resin to remove any precipitation that has occurred during incubation. Otherwise, the precipitated material will co-pellet with the resin in later steps and increase contaminating background levels during analysis.
During the wash steps, it can be difficult to prevent the loss of resin. Loss of resin will skew results, making comparison across samples less reliable. To avoid this potential problem, users may want to perform washes in small spin columns with a MWCO below that of the resin, such as 10 µm. If you are using this approach, do not spin over 2,000g for more than 30 s, and be sure to immediately add fresh buffer after centrifugation to prevent the resin from drying.
MaterIals

REAGENTS
Cells. We have successfully used adherent HeLa, T47D, A549 and untransformed fibroblast cells 28 •
Prepare the buffer using nuclease-free water. 
Box 1 | Fluorescence microscopy of isolated nuclei • tIMInG 2-3 h
Visualization of isolated nuclei is a qualitative method for determining whether nuclei are intact and whether the purification procedure was sufficient to remove contaminants such as ER membrane protein from the surface of nuclei. This method complements the results of western blot analysis. 1. Dilute the nuclei aliquots taken at PROCEDURE Step 7A(iii) or Step 7B(iii) tenfold by adding 90 µl of PBS. Spin the aliquots at 500g for 1 min to pellet them. 2. Gently resuspend the nuclei in 10 µl of PBS containing 1 µM ER Tracker Red dye and incubate it on ice for 20 min. 3. Dilute 10-fold by adding 90 µl of 4% (wt/vol) PFA in PBS. Spot 5 µl of nuclei onto a glass slide and allow it to partially air-dry. 4 . Add 1 drop of Vectashield HardSet mounting medium with DAPI and carefully place a coverslip on top. Allow the mounting medium to harden for 15 min at room temperature. 5. Visualize nuclei at 60× magnification with blue (DAPI) and red (TRITC) filters on a wide-field fluorescence microscope. Collect z-sections through the nuclei at 0.15-µm thickness. Deconvolute images by blind deconvolution. We use AutoQuant X3 (Media Cybernetics) for deconvolution, and we process stacked and pseudocolored images in ImageJ for visualization. Alternatively, nuclei can be visualized using a confocal microscope with appropriate DAPI and TRITC filters. Z-sectioning is optional for this analysis, but it enhances image clarity and assessment of nuclei purity. An example of nuclei imaged by this procedure is shown in Figure 3b .
? trouBlesHootInG (xii) Wash the RNA pellets with 70% (vol/vol) ethanol by vortexing and by centrifugation at 18,000g at room temperature for 5 min. Remove the supernatant and air-dry the pellet. Typical RNA yield ranges from 100 mg of cells are 50-100 µg, 25-75 µg and 15-30 µg for cytoplasmic, nucleoplasmic and chromatin-associated fractions, respectively.  crItIcal step RNA purified from nuclear and chromatin fractions will contain DNA contamination. Treatment with DNase may be required before downstream analysis. DNase treatment and downstream analysis of chromatin-associated RNA are not described here.  pause poInt Purified and dry RNA is stable at −80 °C for long periods of time. (B) preparation of cytoplasmic, total nuclear, nucleoplasmic and chromatin fractions for biochemical assays or protein analysis (i) Resuspend the cell pellet by gentle pipetting with 1 ml of ice-cold HLB for every 75 mg of cells or every 10 million cells. To this cell suspension, add PI cocktail and PhI solution to a final concentration of 1×. Incubate the cells on ice for 10 min. Vortex them briefly.  crItIcal step HLB contains NP-40, which is a detergent that is crucial to the success of ER contamination removal. As a negative control for ER contamination removal, consider lysing cells with no detergent or 0.5% (vol/vol) Tween-20, which will lyse the cell membrane but will leave ER integral membrane proteins intact. (ii) Centrifuge the cell suspension at 800g at 4 °C for 8 min. Transfer the supernatant (cytoplasmic fraction) to a new tube on ice. Add enough 5 M NaCl to this cytoplasmic fraction to equal a concentration of 140 mM (final NaCl concentration is 150 mM), and mix well by gentle inversion. Keep the tube on ice until
Step 7B(vii).  crItIcal step Keep the nuclei pellet on ice to slow the metabolic processes, to inhibit protein degradation and to maintain enzyme activity. (iii) Wash the nuclei pellet from Step 7B(ii) four times by adding HLB, by pipetting and centrifuging at 200g at 4 °C for 2 min. To prepare total nuclear extract, carry out Step 7B(iv). Otherwise, proceed directly to Step 7B(v) to prepare nucleoplasmic and chromatin extracts.  crItIcal step These conditions work well for HeLa cells. Wash steps need to be optimized for different cell types. In general, low-speed spins for short periods are sufficient to wash most nuclei. The nuclei of some cell types can withstand vigorous pipetting, whereas others cannot. Centrifugation speeds can range from 100 to 300g.  crItIcal step Collect a sample of nuclei for analysis of nuclei purity, as described in Box 1.
? trouBlesHootInG (iv) To prepare total nuclear extract, resuspend nuclei from Step 7B(iii) in 0.5 ml of ice-cold NLB for every 75 mg or 10 million cells of the original cell pellet. Add PI cocktail and PhI solution to the nuclei suspension to a final concentration of 1×. Divide the nuclei suspension into aliquots in 15-ml conical tubes at 2-4 ml/tube. Sonicate the nuclei three times at 20% power for 15 s in an ice bath with 2 min of cooling between each sonication. Sonication success can be checked by observing several microliters of lysed nuclei on a glass coverslip with a light microscope. Place the sonicated nuclei extract on ice until Step 7B(vii).  crItIcal step Oversonication can damage proteins and their native complexes. Sonication instruments vary in power and efficiency. ? trouBlesHootInG (v) To prepare nucleoplasmic and chromatin extracts, resuspend nuclei in 0.5 ml of ice-cold MWS buffer for every 75 mg or 10 million cells of the original cell pellet. Add PI cocktail and PhI solution to the nuclei suspension to a final concentration of 1×. Vortex it gently and incubate it on ice for 15 min. Vortex the mixture again and centrifuge it at 1,000g at 4 °C for 5 min. Collect the supernatant as nucleoplasmic fraction and transfer it to a new tube. Place the nucleoplasmic extract on ice until Step 7B(vii).  crItIcal step Do not pipette the chromatin pellet. It will stick to the inside of the pipette tip. (vi) Wash the chromatin pellet twice with MWS buffer by vortexing, by incubating on ice for 5 min and centrifuging at 500g at 4 °C for 3 min. Add 0.5 ml of ice-cold NLB to the chromatin pellet for every 75 mg or 10 million cells of the original cell pellet. Sonicate chromatin three times at 20% power for 15 s in an ice bath with 2 min of cooling between each sonication. Place the sonicated chromatin on ice until Step 7B(vii).  crItIcal step Oversonication can damage proteins and their native complexes. Sonication instruments vary in power and efficiency.  crItIcal step Chromatin extracts contain large amounts of DNA, which may need to be minimized or removed by DNase treatment for some downstream assays. DNase treatment and downstream analysis of the chromatin fraction are not described here. (vii) Centrifuge the cytoplasmic, nuclear, nucleoplasmic and chromatin extracts in 1.5-ml microcentrifuge tubes at 18,000g for 15 min at 4 °C. Pool the supernatants of the respective samples in a new conical tube, invert the tube to mix, and divide the mixture into 1-ml volumes in 1.5-ml microcentrifuge tubes.
 crItIcal step Typical protein concentrations can range from 3-6 mg/ml and 1-3 mg/ml for cytoplasmic and nuclear extracts, respectively.  pause poInt Flash-freeze the samples in liquid nitrogen and store them at −80 °C. Extracts can be stored at −80 °C for several weeks. (viii) Perform western blotting analysis using standard methods to evaluate the extract quality and success; use antibodies that detect subcellular markers such as tubulin (cytoplasm), OxPhos (mitochondria), calreticulin (ER) and lamin A/C (nucleus) 28 . Typical results are shown in Figure 3 . Successful extracts can be used for biochemical analysis in Step 8.  crItIcal step Note that nuclear, nucleoplasmic and chromatin fractions are half the volume of corresponding cytoplasmic extracts. This makes application in biochemical assays more convenient, as the cytoplasm usually has 2-4× more total protein than the nucleus. For western blot analyses, be sure to load half the volume of nuclear versus cytoplasmic extracts. This will give total protein of the same cell equivalents.
In vitro ago2 loading assay • tIMInG 2-3 d 8| If the cell extracts were frozen, thaw them on ice. Centrifuge the cell extract at 18,000g for 10 min at 4 °C. Transfer the supernatant to a new tube. Keep it on ice to avoid degradation or inactivation of enzymes in the extract.
9|
Perform the Ago2 loading assay according to either options A or B. Option A evaluates the accessibility of Ago2 for loading. Ago2 is first immunoprecipitated and then mixed with radiolabeled single-stranded siLuc guide RNA, prepared as described in Box 2. Single-stranded RNA cannot be directly mixed with extract, as it is rapidly degraded, even with the addition of RNase inhibitors. However, Ago2 can bind and load single-stranded small RNAs without the need for accessory proteins. Option B (Fig. 4a) determines the ability of the cell extract to efficiently load a duplex siRNA (prepared as described in Box 2) into Ago2, which requires accessory proteins in mammalian cells.
(a) ago2 accessibility for small rna loading (i) Vortex Protein G PLUS/protein A resin to resuspend it, and then divide it into 40-µl aliquots in four 1.5-ml microcentrifuge tubes. Equilibrate the resin by adding 1 ml of IP EQ buffer and rotating for 5 min at room temperature. Pellet the resin by centrifugation at 2,000g for 30 s at room temperature. Add 1 ml of IP 150 buffer, rotate the tube for 5 min and centrifuge it again. (ii) Prepare the following four reactions and rotate them at room temperature for 1 h. 32 P is radioactive and poses serious health risks. Follow accepted safety procedures, such as Plexiglas shielding, when handling radioactive materials. 2. Phenol-chloroform extract radiolabeled RNA using standard methods.  pause poInt Extracted RNA can be stored at −20 °C for a few days. 3. Divide radiolabeled siLuc guide RNA equally into two tubes. Add 120 pmol of the siLuc passenger strand RNA to one tube and heat it to 90 °C for 3 min. Remove it from the heating block and allow it to cool at room temperature for 15 min. This step generates a duplex siLuc siRNA from the half of the sample that was mixed with passenger strand RNA. One sample is used for the single-stranded RNA probe for Step 9A(vi) and the other as a duplex RNA probe for use in Step 9B(i). 4. Add 5 µl of 4× native loading buffer and resolve the samples on a native 15% (wt/vol) TBE-buffered 19:1 polyacrylamide gel. As an alternative to pouring a gel, native TBE-buffered gels can often be purchased commercially.  crItIcal step Use water cooling and low current to maintain native conditions and to prevent denaturation of the annealed siRNA duplex. Run the gel at 35 mA (the gel should stay below 30 °C) until the lower dye (bromophenol blue) band reaches 2/3 of the way down the gel. 5. Remove the gel from the apparatus. Open the gel cassette and lay a sheet of Saran Wrap over the gel. At three corners of the gel, spot 1 µl of radioactive black India ink and allow it to air-dry (~10 min). Cover the dried ink spots with clear tape. ! cautIon The buffer in the anode tank (the positive electrode that contacts buffer at the bottom of the gel) will be radioactive owing to unincorporated [γ]-32 P-ATP. Discard it carefully in a designated liquid 32 P waste container. Use a Geiger counter to monitor contamination and cleanup. 6. Expose the gel in the darkroom to the autoradiography film placed on top of the gel. Expose it for 15-60 s and develop it. 7. Slide the film under the glass that the gel is on. Orient and align the spots at the three corners of the gel to identify the location of the RNA bands. Gently peel back the Saran Wrap and cut out the band with a flamed razor (RNase free). 8. Crush the gel slice with a 1-ml plastic pipette tip (RNase free and flame sealed at the tip), and pipette 300 µl of nuclease-free water down the side of the tip and into a microcentrifuge tube so as to collect all the gel bits; rotate at 4 °C for 4-16 h. 9. Cut ~2 mm off the end of a 1-ml pipette tip and use it to move the gel bits and solution to an RNase-free filter spin column (~10 µm cutoff). Spin at 2,000g for 2 min to collect the eluted RNA in solution. Discard the gel bits. 10. Add 10 µg of tRNA and split the sample evenly into two microcentrifuge tubes to accommodate the total volume required during precipitation. Precipitate the RNA from the solution by adding 9 volumes of 2% (wt/vol) LiClO 4 in acetone and incubating at −20 °C for >15 min. ! cautIon LiClO 4 is a dangerous oxidizer. Handle it with caution.  crItIcal step The radiolabeled RNA is extremely dilute and it will not precipitate well by standard ethanol precipitation. 11. Spin the mixture at 12,000g for 10 min, wash the pellet with ice-cold acetone and spin it again at 12,000g for 2 min. Allow the pellet to air-dry at room temperature.  pause poInt Dried RNA pellets can be stored at −20 °C for a few days. (ii) While the loading reactions are rotating, prepare the resin for immunoprecipitation. Vortex Protein G PLUS/ protein A resin to resuspend it, and then divide the resin into 40-µl aliquots in four 1.5-ml microcentrifuge tubes. Equilibrate the resin by adding 1 ml of IP EQ buffer and rotating it for 5 min at room temperature. Pellet the resin by centrifugation at 2,000g for 30 s at room temperature. Add 1 ml of IP 150 buffer, rotate it for 5 min and centrifuge it again. (iii) Centrifuge the loading reactions from Step 9B(i) at 12,000g at room temperature for 5 min. Move the supernatant to a 1.5-ml microcentrifuge tube containing equilibrated resin (from Step 9B(ii)). ! cautIon LiClO 4 is a dangerous oxidizer. Handle it with caution. (x) Spin the mixture at 12,000g for 10 min, wash the pellet with ice-cold acetone and spin it again at 12,000g for 2 min.
Allow the pellet to air-dry at room temperature.  pause poInt Dried RNA pellet can be stored at −20 °C for a few days.
10|
Resolve the samples by denaturation or by native gel electrophoresis. Denaturing gel electrophoresis (option A) will not distinguish duplex versus single-stranded guide RNA bound to Ago2, but it will reveal a single band for radioactive RNA bound to Ago2. Native electrophoresis (option B) conditions will separate duplex from single-stranded small RNAs, which may suggest formation of premature and mature RISC complexes, respectively. (a) assessing ago2 loading by denaturing gel electrophoresis (i) Cast a denaturing 15% (wt/vol) polyacrylamide gel. Mix the following components and then pour them into a gel cassette assembled from glass plates, spacers, binder clips and a comb. As an alternative to casting a gel, denaturing TBE-buffered gels can often be purchased commercially. (ii) Prerun the gel at 40 mA with 1× TBE running buffer for 30 min without cooling. The gel should become very warm to the touch and should reach a temperature of ~45-50 °C for optimal denaturation and resolving conditions. ! cautIon If denaturing gels become too hot, the glass plates will crack. Monitor the temperature and current to maintain a safe operating range. (iii) Add 6-10 µl of formamide loading buffer to dried RNA from Step 9A(xii) or Step 9B(x), boil the mixture for 5 min at 90 °C, vortex it, centrifuge it at 2,000g 30 s and then load it onto a prerun gel. Run the gel at 40 mA until the bottom blue dye band (bromophenol blue) is 1/2-2/3 of the way down the gel. The RNA will run between the two blue dye bands on the gel. (iv) Stop the gel, separate the glass plates and lay Saran Wrap over the top of the gel. Flip the gel over and peel the glass plate off so that the gel is now adhered to the Saran Wrap. Press a sheet of Whatman 3M paper to the gel and dry it in a vacuum gel dryer at 80 °C for 2 h. (v) Expose the dried gel to a phosphorimager screen overnight. Develop the screen to visualize radioactive RNA that coeluted with Ago2 in the in vitro loading assay. Typical results for Step 9B samples resolved by native gel electrophoresis are shown in Figure 4b . ? trouBlesHootInG (B) assessing ago2 loading by native gel electrophoresis (i) Cast a native 15% (wt/vol) polyacrylamide gel. Mix the following components and then pour them into a gel cassette assembled from glass plates, spacers, binder clips and a comb. As an alternative to pouring a gel, native TBE-buffered gels can often be purchased commercially. 
